ENDRA Life Sciences (NDRA) EPS (Basic) (2016 - 2026)
ENDRA Life Sciences' (NDRA) quarterly EPS (Basic) came in at $0.12 in Q2 2026, up 107.07% year-over-year from $0.06 in Q2 2025, and up 111.05% quarter-over-quarter from -$1.09 in Q1 2026.
Powered by 
Analysis
ENDRA Life Sciences (NDRA) EPS (Basic) (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported EPS (Basic) for 11 consecutive years, with $0.12 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EPS (Basic) rose 107.07% year-over-year to $0.12 in Q2 2026; TTM through Jun 2026 was -$4.47, a 49.52% increase from a year earlier, with the FY2025 full-year figure at -$7.05, up 84.32% from the prior year.
- EPS (Basic) was $0.12 for Q2 2026 at ENDRA Life Sciences, up from -$1.09 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.12 in Q2 2026 and troughed at -$66.39 in Q1 2022.
- A 5-year average of -$21.17 and a median of -$10.5 in 2023 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) declined 4.91% in 2022 and jumped 107.07% in 2026, its largest moves.
- Over 5 years, EPS (Basic) stood at -$56.89 in 2022, then soared by 79.84% to -$11.47 in 2023, then rose by 25.26% to -$8.57 in 2024, then surged by 53.02% to -$4.03 in 2025, then soared by 103.0% to $0.12 in 2026.
- The last three EPS (Basic) figures came in at $0.12 (Q2 2026), -$1.09 (Q1 2026), and -$4.03 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 1.27 |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 1.15 |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | -0.18 |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | -0.05 |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | -0.05 |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | -0.51 |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 0.38 |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | - |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - | 0.12 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.12 |
| Mar 31, 2026 | -1.09 |
| Dec 31, 2025 | -4.03 |
| Sep 30, 2025 | -2.10 |
| Jun 30, 2025 | -1.71 |
| Mar 31, 2025 | -1.86 |
| Dec 31, 2024 | -8.57 |
| Sep 30, 2024 | -9.54 |
| Jun 30, 2024 | -4.09 |
| Mar 31, 2024 | -12.84 |
| Dec 31, 2023 | -11.47 |
| Sep 30, 2023 | -20.18 |
| Jun 30, 2023 | -21.32 |
| Mar 31, 2023 | -46.43 |
| Dec 31, 2022 | -56.89 |
| Sep 30, 2022 | -54.46 |
| Jun 30, 2022 | -58.25 |
| Mar 31, 2022 | -66.39 |
| Dec 31, 2021 | -75.87 |
| Sep 30, 2021 | -63.42 |